SYKStryker Corporation
Price
-26%1YEnd-of-day closes, not the intraday tick.
More going right than wrong
Quality strong, no red flags, price roughly fair, growing in the filings, the market undecided.
Stryker Corporation (Stryker or the Company) is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside our customers around the world, we impact more than 150 million patients annually. Stryker was incorporated in Michigan in 1946 as the successor company to a business founded in 1941 by Dr. Homer H. Stryker, a prominent orthopaedic surgeon and inventor of several medical products.
In the company’s own words · 10-K filed Feb 11, 2026 · SEC EDGAR
Charts
As reported to the SEC, without any scoring.
Stryker Corporation (SYK) reported revenue of $6.59B in Q2 2026 (quarter ended Jun 30, 2026), up 9.4% from the same quarter a year earlier. That came with a gross margin of 68% and net income of $1.28B (19% of revenue). For the full year FY2025, revenue was $25.1B (+11% year on year) and net income $3.25B. Its largest product in Q2 2026 was Traumaand Extremities at $1.07B, 16% of the disclosed total, just ahead of Endoscopy at 15%. The next results filing is expected around Oct 29, 2026, the same week as a year ago.
What the company said
The company's own words from its current reports to the SEC, newest first
- Oct 6, 2026Stryker Corporation (the “Company”) announced on October 6, 2026 that Kevin A. Lobo will resign from his role as Chief Executive Officer (“CEO”) of the Company on December 31, 2026 and transition to the role of Executive Chair of the Board of Directors of the Company (the “Board”), effective January 1, 2027 (the “CEO …Director or officer change · Form 8-K
- Jul 30, 2026Portage, Michigan - July 30, 2026 - Stryker (NYSE:SYK) reported operating results for the second quarter of 2026:.Earnings release · press release
- Jun 26, 2026Segment Reporting Changes In the first quarter 2026 Stryker Corporation ("we" or the "Company") announced a change in our organizational structure.Other event · Form 8-K
Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.
Business segments
Q2 2026 · $6.89BThe company’s own SEC segment disclosure.
- Trauma and Extremities$1.07B16%
- Endoscopy$1.00B15%
- Instruments$1.00B15%
- Ortho Tech$717.0M10%
- Knees$693.0M10%
- Neuro Cranial Instruments$681.0M10%
- Other (6)$1.72B25%
Why these answers
Each answer with the checks it was read from. Open one for the numbers.
Conflicts between checks are named, never averaged, and thin data says so.
Medical Devices
Ranks #6 of 51 by RyuScore